Altor BioScience fitted-out their existing campus to support the development and production of their immunotherapies for the treatment of cancer and viral infections.
The five-building campus was near construction complete and IPS continued with the design, building, and commissioning of the interior fit-out. The schedule was the primary driver for this project; IPS executed a fast-track, Integrated Project Delivery (IPD) plan, with an emphasis on utilizing design-assist programs.
IPS partnered with local subcontractors to leverage their knowledge of the local trades to get the project moving at a quick pace. This high level of coordination throughout all phases of the project allowed construction activities to commence while designs were being finalized.
Building 3 was repurposed for use as a CGMP cell culture clinical pilot plant. The first floor is entirely CGMP clinical operating space. The second floor is reserved for support space including MTS & micro-QC lab space, CGMP clean & wash space, office space and utility space.
This project had unique technical challenges related to working with a small foot-print, space was at a premium. Every element was carefully placed in a well thought-out design and material flow plan to allow for maximum utilization of space.
Region: AmericasCountry: United StatesOffice: Irvine, CA
Services: Engineering, Process, Procurement, Construction Management, CQV Program DevelopmentIndustry: PharmaceuticalFacility Type: Manufacturing
Kevin R. Batche
Sr. Director Procurement
David P. Buynak
CA Regional Manager, Compliance
Sr. Director, Business Process Optimization
Global Director, Environmental, Health & Safety
Thomas J. Piombino
Vice President, Biotechnology Process Architect
Mark E. Rezac, PE
Director, Compliance Services
Gary A. Rhodes, PE
Lead Process Engineer
Sr. Director, Validation Services